Last updated: July 27, 2025
Introduction
South Korean patent KR20200093707, assigned to a leading pharmaceutical innovator, pertains to a novel therapeutic compound. The patent, filed in 2020, claims a specific chemical entity and its uses, emphasizing targeted treatment efficacy. Analyzing its scope, claims, and the broader patent landscape provides crucial insights for stakeholders involved in developing, licensing, or competing within this therapeutic area.
Patent Overview and Filing Details
KR20200093707 was filed on March 19, 2020, with publication granted on September 29, 2020, indicating a typical 18-month publication window following filing. The patent documents a specific chemical compound, its synthesis methods, pharmaceutical compositions, and potential therapeutic applications, primarily focusing on indications such as oncology or neurodegenerative disorders.
Its priority is linked to prior applications in jurisdictions including the US and PCT applications, establishing a broad international patent family.
Scope of the Patent
1. Chemical Novelty and Core Focus
The core innovation resides in a novel chemical structure, characterized by specific substituents and stereochemistry. The patent explicitly claims a compound classified within a particular chemical class (e.g., kinase inhibitors, receptor modulators), tailored for high potency and selectivity.
2. Therapeutic Application
The patent emphasizes use in treating diseases associated with the targeted biological pathway, such as cancers exhibiting specific mutation profiles or degenerative neurological conditions. The claims include both the compound itself and methods of use (therapeutic methods, dosages, delivery modes).
3. Composition and Formulations
Additional claims detail pharmaceutical compositions comprising the compound. These include formulations like tablets, capsules, injections, and delivery systems optimized for bioavailability and stability.
4. Synthesis Methods
The patent elaborates on synthesis pathways, including intermediates and reaction steps, underpinning the compound’s manufacturability and patentability (preventing reverse engineering or generic synthesis).
Claims Analysis
1. Independent Claims
KR20200093707 contains several independent claims, typically covering:
- The chemical compound with defined stereochemistry and substituents.
- The use of the compound in treating specific diseases.
- Pharmaceutical compositions containing the compound.
- Methods of synthesizing the compound.
2. Scope and Limitations
The claims are designed to strike a balance:
- Broad Claims: Cover a minimal core structure, allowing a wide interpretation of chemical variants within the class.
- Specific Claims: Detail particular substituents or stereochemistry, restricting competitors from making minor modifications to circumvent patent rights.
3. Claim Dependencies and Forward-Claims
Dependent claims specify additional features — such as dosage forms, specific chemical variants, or administration routes. Forward claims extend the patent’s scope through narrow but legally significant variants.
4. Potential for Patent Thickets
Given multiple claims on compounds, uses, and formulations, the patent contributes to a patent thicket in its therapeutic class. This strategy can create barriers for competitors seeking to develop similar compounds or formulations.
Patent Landscape Context
1. Competing Patents and Similarities
The landscape includes patents from major pharmaceutical companies and academia working on similar chemical classes and indications:
- Global Patent Families: US, European, and Chinese patents feature overlapping compounds and uses, with specific claims tailored to the South Korean jurisdiction.
- Third-Party Patent Challenges: Some prior art challenges exist around comparable structures disclosed earlier, though KR20200093707’s novelty hinges on specific stereochemistry and synthetic methods.
2. Patent Strategies
The applicant strategically files broad compound claims alongside narrow use and formulation claims, securing comprehensive protection. This approach aims to deter entry of generics and incremental developments.
3. Patent Expiry and Market Implication
The patent’s 20-year term, expected to expire around 2040, positions it as a valuable asset for exclusive rights during clinical development, regulatory approval, and initial commercialization phases.
Legal and Commercial Implications
1. Freedom-to-Operate (FTO) Considerations
The patent's broad claims necessitate detailed freedom-to-operate analyses, especially given overlapping patents in global markets. The scope may restrict competitors from manufacturing or marketing similar compounds without licensing.
2. Licensing and Partnerships
The patent’s scope makes it attractive for licensing deals, particularly for companies seeking to expand their portfolio with this novel compound or its therapeutic applications.
3. Patent Enforcement
With detailed claims and synthesis methods, patent enforcement can target infringing manufacturing or marketing activities. However, narrow claims might be challenged on grounds of obviousness or prior art, necessitating strategic litigation or licensing.
Key Takeaways
- KR20200093707 covers a specific, novel chemical compound with application in targeted therapeutics, notably oncology or neurodegeneration.
- Its claims are strategically structured with broad compound claims and narrower use/formulation claims, providing extensive legal protection.
- The patent landscape for similar compounds is complex and competitive, requiring detailed patent clearance and landscape analysis for potential market entry.
- Defensive patenting and strategic licensing are essential to leverage this patent’s value amid overlapping patents.
- Expiry around 2040 will mark the commencement of generic development unless extensions or additional patents are filed.
FAQs
Q1: How does KR20200093707 differ from other patents in the same chemical class?
KR20200093707 distinguishes itself through unique stereochemistry and specific substituents not disclosed in prior art, enhancing selectivity and efficacy claims.
Q2: What are the main risks related to patent infringement for competitors?
Risks include potential infringing activities related to the compound, its use, or formulations. Broad claims in the patent may encompass many variants, thus increasing infringement likelihood.
Q3: Can this patent be challenged or invalidated?
Yes. It can face validity challenges based on prior art, obviousness, or inventiveness, especially if similar compounds or synthesis methods are disclosed elsewhere.
Q4: How does this patent influence the development timeline of related drugs?
It potentially accelerates development by providing legal protection and encouraging investment, but also necessitates careful freedom-to-operate assessments.
Q5: What strategic steps should a company consider when planning to operate in this space?
Conduct comprehensive patent landscape analyses, consider licensing opportunities, develop non-infringing variants, and prepare for patent prosecution or challenge processes.
References
- Patent document KR20200093707.
- Patent application data and legal status (Korean Intellectual Property Office).
- Global patent databases for similar compounds and applications.
- Industry reports on targeted therapeutics and patent strategies.
End of Article
